rs62623378

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_018897.3(DNAH7):​c.3059T>C​(p.Ile1020Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0985 in 1,563,484 control chromosomes in the GnomAD database, including 8,409 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.082 ( 683 hom., cov: 32)
Exomes 𝑓: 0.10 ( 7726 hom. )

Consequence

DNAH7
NM_018897.3 missense

Scores

2
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.55

Publications

7 publications found
Variant links:
Genes affected
DNAH7 (HGNC:18661): (dynein axonemal heavy chain 7) DNAH7 is a component of the inner dynein arm of ciliary axonemes (Zhang et al., 2002 [PubMed 11877439]).[supplied by OMIM, Mar 2008]
DNAH7 Gene-Disease associations (from GenCC):
  • ciliary dyskinesia, primary, 50
    Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • male infertility with azoospermia or oligozoospermia due to single gene mutation
    Inheritance: AR Classification: LIMITED Submitted by: King Faisal Specialist Hospital and Research Center

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0029920936).
BP6
Variant 2-195957280-A-G is Benign according to our data. Variant chr2-195957280-A-G is described in ClinVar as Benign. ClinVar VariationId is 377778.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.11 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH7NM_018897.3 linkc.3059T>C p.Ile1020Thr missense_variant Exon 19 of 65 ENST00000312428.11 NP_061720.2 Q8WXX0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH7ENST00000312428.11 linkc.3059T>C p.Ile1020Thr missense_variant Exon 19 of 65 1 NM_018897.3 ENSP00000311273.6 Q8WXX0-1

Frequencies

GnomAD3 genomes
AF:
0.0817
AC:
12423
AN:
152076
Hom.:
683
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0206
Gnomad AMI
AF:
0.0870
Gnomad AMR
AF:
0.0871
Gnomad ASJ
AF:
0.156
Gnomad EAS
AF:
0.00115
Gnomad SAS
AF:
0.0843
Gnomad FIN
AF:
0.125
Gnomad MID
AF:
0.209
Gnomad NFE
AF:
0.112
Gnomad OTH
AF:
0.0957
GnomAD2 exomes
AF:
0.0899
AC:
21205
AN:
235866
AF XY:
0.0951
show subpopulations
Gnomad AFR exome
AF:
0.0165
Gnomad AMR exome
AF:
0.0611
Gnomad ASJ exome
AF:
0.151
Gnomad EAS exome
AF:
0.000413
Gnomad FIN exome
AF:
0.118
Gnomad NFE exome
AF:
0.109
Gnomad OTH exome
AF:
0.117
GnomAD4 exome
AF:
0.100
AC:
141571
AN:
1411290
Hom.:
7726
Cov.:
31
AF XY:
0.102
AC XY:
70849
AN XY:
696516
show subpopulations
African (AFR)
AF:
0.0184
AC:
595
AN:
32406
American (AMR)
AF:
0.0656
AC:
2730
AN:
41614
Ashkenazi Jewish (ASJ)
AF:
0.153
AC:
3846
AN:
25110
East Asian (EAS)
AF:
0.000366
AC:
14
AN:
38212
South Asian (SAS)
AF:
0.0969
AC:
7838
AN:
80866
European-Finnish (FIN)
AF:
0.112
AC:
5894
AN:
52430
Middle Eastern (MID)
AF:
0.181
AC:
924
AN:
5110
European-Non Finnish (NFE)
AF:
0.106
AC:
113747
AN:
1077714
Other (OTH)
AF:
0.103
AC:
5983
AN:
57828
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
6221
12441
18662
24882
31103
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4192
8384
12576
16768
20960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0816
AC:
12414
AN:
152194
Hom.:
683
Cov.:
32
AF XY:
0.0816
AC XY:
6071
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.0205
AC:
853
AN:
41532
American (AMR)
AF:
0.0869
AC:
1328
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.156
AC:
543
AN:
3470
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5188
South Asian (SAS)
AF:
0.0844
AC:
407
AN:
4822
European-Finnish (FIN)
AF:
0.125
AC:
1328
AN:
10582
Middle Eastern (MID)
AF:
0.207
AC:
61
AN:
294
European-Non Finnish (NFE)
AF:
0.112
AC:
7609
AN:
68000
Other (OTH)
AF:
0.0947
AC:
200
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
572
1144
1715
2287
2859
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
154
308
462
616
770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0991
Hom.:
2072
Bravo
AF:
0.0742
TwinsUK
AF:
0.0944
AC:
350
ALSPAC
AF:
0.0929
AC:
358
ESP6500AA
AF:
0.0206
AC:
77
ESP6500EA
AF:
0.118
AC:
972
ExAC
AF:
0.0892
AC:
10781
Asia WGS
AF:
0.0330
AC:
116
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
May 13, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

DNAH7-related disorder Benign:1
Mar 11, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
14
DANN
Benign
0.97
DEOGEN2
Benign
0.15
T
Eigen
Benign
-0.36
Eigen_PC
Benign
-0.24
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Benign
0.66
T
MetaRNN
Benign
0.0030
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.1
L
PhyloP100
2.5
PrimateAI
Benign
0.47
T
PROVEAN
Uncertain
-2.9
D
REVEL
Benign
0.23
Sift
Benign
0.13
T
Polyphen
0.0050
B
Vest4
0.15
MPC
0.034
ClinPred
0.0062
T
GERP RS
4.4
Varity_R
0.14
gMVP
0.47
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62623378; hg19: chr2-196822004; COSMIC: COSV107351791; API